Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autism Spectrum Disorder | 4 | 2022 | 322 | 1.760 |
Why?
|
| Catatonia | 3 | 2023 | 10 | 1.680 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 2 | 2021 | 14 | 1.410 |
Why?
|
| Autoimmune Diseases of the Nervous System | 2 | 2023 | 21 | 0.920 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 9 | 0.880 |
Why?
|
| Encephalitis | 2 | 2023 | 127 | 0.820 |
Why?
|
| Adolescent Development | 1 | 2020 | 84 | 0.690 |
Why?
|
| Electroconvulsive Therapy | 1 | 2018 | 8 | 0.630 |
Why?
|
| Suicidal Ideation | 2 | 2023 | 397 | 0.570 |
Why?
|
| Body Mass Index | 2 | 2022 | 1967 | 0.550 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2017 | 33 | 0.550 |
Why?
|
| Medical Records | 1 | 2017 | 155 | 0.530 |
Why?
|
| Puberty | 3 | 2022 | 137 | 0.510 |
Why?
|
| Pediatric Obesity | 1 | 2020 | 492 | 0.460 |
Why?
|
| Suicide, Attempted | 1 | 2017 | 314 | 0.450 |
Why?
|
| Self-Injurious Behavior | 2 | 2023 | 114 | 0.390 |
Why?
|
| Internship and Residency | 1 | 2017 | 941 | 0.290 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 2389 | 0.270 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 394 | 0.260 |
Why?
|
| Child | 11 | 2023 | 18407 | 0.260 |
Why?
|
| Adolescent | 9 | 2023 | 17862 | 0.240 |
Why?
|
| International Classification of Diseases | 2 | 2023 | 116 | 0.240 |
Why?
|
| Hospitalization | 2 | 2022 | 1754 | 0.200 |
Why?
|
| Female | 12 | 2023 | 59610 | 0.200 |
Why?
|
| Aggression | 1 | 2023 | 184 | 0.190 |
Why?
|
| Confusion | 1 | 2021 | 25 | 0.190 |
Why?
|
| Humans | 16 | 2023 | 115038 | 0.190 |
Why?
|
| Delirium | 1 | 2021 | 66 | 0.180 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 39 | 0.170 |
Why?
|
| Endocrine System Diseases | 1 | 2019 | 30 | 0.170 |
Why?
|
| Male | 10 | 2023 | 55729 | 0.170 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2019 | 32 | 0.160 |
Why?
|
| Malnutrition | 1 | 2019 | 61 | 0.160 |
Why?
|
| Referral and Consultation | 1 | 2023 | 633 | 0.160 |
Why?
|
| Physical Examination | 1 | 2019 | 221 | 0.150 |
Why?
|
| Sexual Behavior | 1 | 2022 | 440 | 0.150 |
Why?
|
| Psychotic Disorders | 1 | 2019 | 120 | 0.150 |
Why?
|
| Sex Characteristics | 2 | 2020 | 635 | 0.150 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 253 | 0.150 |
Why?
|
| Communicable Diseases | 1 | 2019 | 130 | 0.150 |
Why?
|
| Benzodiazepines | 1 | 2018 | 116 | 0.150 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 4411 | 0.140 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 117 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 252 | 0.140 |
Why?
|
| Self Report | 1 | 2019 | 698 | 0.130 |
Why?
|
| Seizures | 1 | 2018 | 341 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2020 | 606 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 484 | 0.120 |
Why?
|
| Mental Health | 1 | 2020 | 559 | 0.120 |
Why?
|
| Mass Screening | 1 | 2021 | 1012 | 0.120 |
Why?
|
| Mental Disorders | 1 | 2020 | 897 | 0.100 |
Why?
|
| Parents | 1 | 2019 | 1189 | 0.100 |
Why?
|
| Poverty | 1 | 2013 | 443 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1811 | 0.080 |
Why?
|
| Students | 1 | 2013 | 499 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 642 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 1812 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2017 | 2976 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2022 | 1132 | 0.070 |
Why?
|
| Risk Factors | 1 | 2017 | 8642 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2023 | 331 | 0.050 |
Why?
|
| United States | 1 | 2017 | 12224 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2017 | 12547 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 307 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 62 | 0.040 |
Why?
|
| Streptolysins | 1 | 2019 | 8 | 0.040 |
Why?
|
| Calcium Channels, N-Type | 1 | 2019 | 5 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6232 | 0.040 |
Why?
|
| Lorazepam | 1 | 2019 | 23 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 21 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2019 | 60 | 0.040 |
Why?
|
| Fluoxetine | 1 | 2019 | 46 | 0.040 |
Why?
|
| Comorbidity | 1 | 2023 | 1457 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 119 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 134 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 618 | 0.040 |
Why?
|
| Anxiety | 1 | 2023 | 845 | 0.030 |
Why?
|
| Data Collection | 1 | 2019 | 623 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 30654 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2255 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1488 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1355 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 767 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2799 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 736 | 0.030 |
Why?
|
| Texas | 1 | 2013 | 187 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 4904 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2019 | 1354 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 4420 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 5040 | 0.020 |
Why?
|
| Schools | 1 | 2013 | 400 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 9093 | 0.020 |
Why?
|
| Infant | 1 | 2021 | 7945 | 0.020 |
Why?
|